Fellows Research

Peer Reviewed Journal Articles

  1. Rice DP, Ordoveza MA, Palmer AM, Wu GY, Chirch LM. Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients. AIDS Care 2018 Dec;30(12):1507-1511. Epub 2018 Jul 18. PMID: 30021452
  2. Ivanaviciene J, Chirch LM, Grant-Kels J, Kerr P, Finch J. Ecthyma Gangrenosum Secondary to Methicillin-Sensitive Staphylococcus aureus. International Journal of Women's Dermatology 2016 Sept. PMID 28492017.
  3. Rice DP Jr, Faragon JJ, Banks S, Chirch LM. HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals. J Clin Transl Hepatol. 2016 Sep 28;4(3):234-240. PMID: 27777891.
  4. Anthony P, Feinn R, Brenner B, Dieckhaus KD, Chirch LM. The Addition of High-Risk HPV Testing to Anal Cytology Increases the Identification of Anal Dysplasia in HIV-Infected Patients. Conn Med. 2015 Aug; 79(7):389-94. PMID 26411174.
  5. Hypolite T, Grant-Kels JM, Chirch LM. Nontuberculous mycobacterial infections: a potential complication of cosmetic procedures. International Journal of Women's Dermatology, Vol. 1, Issue 1, p51–54. Published online: February 24 2015. PMID 28491956.
  6. Chirch LM, Hasham M, Kuchel GA. HIV and aging: a clinical journey from Koch's postulate to the chronic disease model and the contribution of geriatric syndromes. Curr Opin HIV AIDS. 2014 Jul;9(4):405-11. PMID 24824883.
  7. Chirch LM, Cataline P, MD, Dieckhaus KD, Grant-Kels JM. Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists. Risks associated with tumor necrosis factor–alfa antagonists, Part I. J Am Acad Dermatol 2014. PMID 24947698.
  8. Chirch LM, Cataline P, MD, Dieckhaus KD, Grant-Kels JM. Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists, Part II. J Am Acad Dermatol 2014. PMID 24947699.
  9. Cloherty G, Swanson P, Lucic D, Dieckhaus K, Anthony P, Cataline P, Herman C, Hackett J Jr, Skolnik PR, Chirch L. Clinical implications of elevated HIV-1 viral load results obtained from samples stored frozen in vacutainer plasma preparation tubes. Journal of Virological Methods 204 (2014) 91–92. PMID 24747107.
  10. Gemtessa TA and Chirch LM. Update on Hepatitis C Virus and HIV Coinfection. Journal of Clinical and Translational Hepatology 2013 vol. 1 | 109–115. PMID 26355698.
  11. Mohamed KA, Bromberg R, Banach D. Legionella pneumonia associated with tumor necrosis factor inhibition [published online June 10, 2019]. Infectious Diseases Consultant.
  12. Abrantes-Figuerido JA, Ross JW, Banach DB (corresponding author). Device utilization ratios in infection prevention: process or outcome measure? Current Infectious Diseases Reports 2018 23;20(5):8
  13. Snayd M, Dias F, Ryan RW, Clout D, Banach DB (corresponding author). The misidentification of Candida auris using RapID Yeast Plus, a commercial biochemical enzyme-based manual rapid identification system. Journal of Clinical Microbiology 2018:2556(5)1-2.

Books and Book chapters

  1. HIV and GI Tract Complications: A Comprehensive Clinical Guide. Lisa M. Chirch and Jurate Ivanaviciene, Editors. Springer Nature Switzerland AG 2019.
  2. “Viral Exanthems”. Romina Bromberg, Michael Thompson, Lisa M. Chirch, and Jane Grant-Kels. Clinical Infectious Diseases, David Schlossberg, Ed. 2019 edition in press.
  3. Abrantes-Figueiredo J, Feroz J, Manu C, Banach D. Osteomyelitis in Interdisciplinary Approach to Limb Salvage of the Diabetic Foot. Sumpio B, Edmonds M (eds). Springer; 2019.
  4. Wasser J, Edmonds M, Banach D. Medical Management of the Infected Diabetic Foot in Interdisciplinary Approach to Limb Salvage of the Diabetic Foot. Sumpio B, Edmonds M (eds). Springer; 2019.

Poster Presentations

  1. Thompson M, Banach D, Nishimura C, Muyombwe A. Challenges in using MALDI-TOF technology to assess for KPC-resistance in Klebsiella pnuemoniae isolates in America. ID Week 2019. Washington, DC. (Abstract 536).
  2. Nicholas Saba, Sarah Banks MD, Michael Einstein MD, George Wu MD, Dorothy Wakefield, Lisa Chirch MD. Efficacy of Second Generation Direct Acting Antivirals in the Setting of HCV/HIV Coinfection and Cirrhosis: A Review of Real World Treatment Experiences. ID Week 2019, October 2019, Washington, DC.
  3. Anne Abbate MPH, Michael Thompson DO, Sabina Zawadzka DO, Dorothy Wakefield MS, Faryal Mirza MD, Lisa M. Chirch MD. Fragility Fracture Risk in HIV: Awareness Among Primary Care Providers. ID Week 2019, October 2019, Washington, DC.
  4. Snayd M, Leung V, Maloney M, Durante A, Macierowski B, Razeq J, Banach D. Fosfomycin resistance among Carbapenem-resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017. ID Week 2018. San Francisco, CA. 2018. (Abstract 2396).
  5. Tuan J, Abrantes J, Banach D, Chirch L. “Cerebral and Cerebellar Toxoplasmosis Presenting with Disseminated MAC Co-Infection in a Patient with HIV/AIDS.” CDC International Conference Emerging Infectious Diseases, CDC International Conference Emerging Infectious Diseases, August 2018, Atlanta, GA.
  6. Zawadzka S, Thompson M, Abbate A, Chirch L, Mirza F. Evaluation of Bone Health Screening Practices Among HIV and Primary Care Providers. ENDO 2018, March 17-20, Chicago, IL.
  7. Donald P. Rice, Michelle Ordoveza, Ann Palmer, George Wu, Lisa M. Chirch. What are we waiting for? Delay in therapy for Hepatitis C in the era of direct acting antiviral therapy. ID Week 2016, October 26-30, New Orleans, LA.
  8. Tiara T. Hypolite, Jacob W. Hopkins, Lisa M. Chirch and Laura Haynes. The Effects of Aging on CD4+ T Lymphocytes in Flu Infected Mice. ID Week 2015, October 8-12, San Diego, CA.
  9. Hana Javaid, Lisa Chirch, Jeffrey Aeschlimann. Probabilities of Achieving Therapeutic Vancomycin Trough Concentration in Obese versus Non-Obese Patients. Abstract 42577. ID Week 2013, October 1-5, San Francisco, CA.
  10. Gavin Cloherty, Priscilla Swanson, Danijela Lucic, Kevin Dieckhaus, Paul Anthony, Philip Cataline, Christine Herman, John Hackett Jr., Paul Skolnik, Lisa Chirch. Falsely elevated HIV-1 viral load results observed with Roche TaqMan HIV-1 v2.0 from samples stored frozen in Vacutainer plasma preparation tubes not observed with Abbott RealTime HIV-1. HIV Drug Resistance Workshop, June 2013, Toronto, ON.
  11. Paul R. Anthony, Bruce Brenner, Richard Feinn, Kevin Dieckhaus, Lisa M. Chirch. University Anal Cancer screening in a University-based HIV clinic. Connecticut Infectious Diseases Society Meeting, New Haven, CT, May, 2013.
  12. P. Mota, S. Dost, A. Bergner, H. Javaid, L. Chirch, T. Mathew, M. Bidros, J.S. Wasser. Hemophagocytic Lymphohistiocytosis – A zebra in the pack. Society of General Internal Medicine Annual Meeting, April 2013, Denver, CO.